Loading clinical trials...
Loading clinical trials...
A Phase I/II Double-Blind, Randomized Study of the Safety, Tolerability and Systemic Absorption of TMC120 Vaginal Microbicide Gel and Matching Placebo in Healthy HIV-Negative Women.
Conditions
Interventions
dapivirine (TMC120) vaginal gel
Locations
4
Rwanda
Projet Ubuzima
Kigali, Rwanda
Reproductive Health Research Unit - Sheshisani IPM Clinic
Yeoville, Johannesburg, South Africa
Farmovs-Parexel
Bloemfontein, South Africa
Kilimanjaro Reproductive Health Program
Moshi, Tanzania
Start Date
October 1, 2005
Completion Date
July 1, 2006
Last Updated
July 31, 2006
NCT06694805
NCT04142047
NCT07428330
NCT07225530
NCT05897099
NCT06665646
Lead Sponsor
International Partnership for Microbicides, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions